Rob Ruijtenbeek
's-hertogenbosch, NB 5211HH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Kinomic profiling to predict sunitinib response of patients with metastasized clear cell Renal Cell Carcinoma.
Journal: Neoplasia (New York, N.Y.)
Published: July 23, 2024
Cell Death Triggers Induce MLKL Cleavage in Multiple Myeloma Cells, Which may Promote Cell Death.
Journal: Frontiers in oncology
Published: March 29, 2022
Esterified derivatives of DHA and EPA increase bortezomib cytotoxicity in human multiple myeloma cells.
Journal: European journal of pharmacology
Published: October 05, 2021
A public-private partnership model for COVID-19 diagnostics.
Journal: Nature biotechnology
Published: September 29, 2021
Blood-based kinase activity profiling: a potential predictor of response to immune checkpoint inhibition in metastatic cancer.
Journal: Journal for immunotherapy of cancer
Published: November 15, 2020
Erratum: Krayem, M., et al. Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance Short Title: Sensitivity Prediction to MAPK Inhibitors in Melanoma. Cancers 2020, 12, 512.
Journal: Cancers
Published: September 24, 2020
Last Updated: 09/26/2026